A Biotech Stock With High FDA Approval Odds For A Rare Disorder In November, However...

A biotech stock with strong FDA approval odds this November may see limited upside amid a full valuation and a pending lawsuit.

Semaglutide showdown: Pills or shots—Which is right for you?

This article was reviewed by Darragh O’Carroll, MD. Oral vs. Injectable Semaglutide: Effectiveness & Side Effects Key takeaways: You can get semaglutide injections (Ozempic® and Wegovy®) ...

What are some safe Ozempic alternatives for weight loss?

This article was reviewed by Darragh O’Carroll, MD. Ozempic Alternatives for Weight Loss Key takeaways: Ozempic® alternatives ...
Opinion

Amarin Issues Statement Supporting FDA’s Action to Revise Labeling for Fenofibrate Drugs Reinforcing a Lack of Cardiovascular Benefit

Science must guide treatment decisions, and healthcare practitioners must take decisive action now to stop inappropriate fibrate prescribing for cardiovascular risk reduction, especially on top of ...
MedPage Today

FDA Approves GLP-1 Pill for Primary, Secondary Cardiovascular Protection

The FDA approved oral semaglutide (Rybelsus) to prevent major adverse cardiovascular events (MACE) in high-risk patients with diabetes, whether or not they've had such an event already, Novo Nordisk ...
New Atlas

First oral GLP-1 cuts cardiovascular risk by 14% – and it's now FDA-approved

An oral GLP-1 receptor agonist, Rybelsus will be available in 7-mg and 14-mg doses. "As the only FDA-approved GLP-1 therapy in a pill, now recognized for its proven cardiovascular benefits, a new ...
Wall Street Journal

FDA Approves Novo Nordisk’s Rybelsus Diabetes Pill to Reduce Heart Risk

The Food and Drug Administration approved Novo Nordisk’s NOVO.B-0.26%decrease; red down pointing triangle oral GLP-1 medication to reduce the risk of major cardiovascular events in high-risk adults ...

What Is GLP-1 Microdosing and Does It Lead to Weight Loss? Doctors Explain

People are trying mini doses of GLP-1 drugs to lose weight or maintain weight loss, but doctors urge caution, calling the ...
WCVB Channel 5 Boston

FDA clears blood test to help rule out Alzheimer’s disease in people showing symptoms

The U.S. Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of when the ...
Healio

FDA updates Rinvoq indication for use after one approved systemic therapy

Please provide your email address to receive an email when new articles are posted on . The FDA has approved a supplemental new drug application that updates the indication statement for upadacitinib ...
WKYC3

Cleveland Clinic performs first FDA-approved surgery for stroke recovery in Ohio

CLEVELAND — More than 795,000 Americans experience a stroke each year, with nearly half of survivors living with physical disabilities. For decades, rehabilitation has been the only option for ...
Nature

FDA new drug approvals in Q3 2025

The third quarter of 2025 delivered a welcome bolus of novel FDA drug approvals, with the 16 approvals in the quarter matching the 16 approvals in total in the first half of the year (Table 1).